global healthcare
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
global healthcare
Jun 28, 2024, 15:39 |
Blog
Gevorg Tamamyan: Everyone involved in pediatric oncology needs to be part of our global movement of conquering childhood cancer with SIOP
Gevorg Tamamyan shared on LinkedIn: “The wonderful trip to Japan is coming to its end!…
Jun 27, 2024, 03:32 |
Blog
Elena Rizova is the new journey as the Chief Medical Officer at Stallergenes Greer
Elena Rizova, EVP, Chief Medical Officer at Stallergenes Greer, made the following post on LinkedIn:…
Jun 10, 2024, 06:58 |
Blog
Yasmine Hassan: Just wrapped up an amazing ASCO conference, now gearing up for the upcoming EHA
Yasmine Hassan, Global Patient Affairs Director at AstraZeneca, made the following post on LinkedIn: "Just…
May 24, 2024, 13:18 |
Blog
Thomas Biegi: I had the honor of participating in a panel discussion during The Leukemia and Lymphoma Society’s event 'TAP Into a Cure'
Thomas Biegi, Senior Vice President, Head of Corporate Affairs at MorphoSys, made the following post…
May 2, 2024, 01:34 |
Blog
Estela Rodriguez: Just 1 week to go for the Sylvester Cancer Miami Precision Medicine 2024 and Patient Symposium
Estela Rodriguez shared a post on X: "Just 1 week to go for the Sylvester Comprehensive…
Apr 28, 2024, 15:17 |
Blog
Mariam AlHilli: Rich and inspiring panel discussions on innovations in healthcare at C3 Summit
Mariam AlHilli, Associate Professor of Surgery at Case Western Reserve University, shared on their X/Twitter:…
All:
6
Posts:
1 - 10
We need to hurry up, because cancer and patients cannot wait!
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Facebook
RSS Feed
Twitter
Linkedin
Youtube